Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis - PubMed (original) (raw)
. 2000 Feb 5;268(1):178-82.
doi: 10.1006/bbrc.2000.2096.
Affiliations
- PMID: 10652233
- DOI: 10.1006/bbrc.2000.2096
Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis
J Masugi et al. Biochem Biophys Res Commun. 2000.
Abstract
Peroxisome proliferator-activated receptor-gamma (PPARgamma) is a member of the nuclear hormone receptor superfamily of transcription factors and appears to be a key regulator of adipogenesis. Members of the thiazolidinedione class of insulin-sensitizing agents act as high-affinity ligands for PPARgamma, indicating that PPARgamma is also important in systemic insulin action. To determine whether Pro(12) --> Ala (P12A) mutation in PPARgamma gene contributes to the development of obesity or insulin sensitivity, we examined the effects of the P12A mutation on the function of PPARgamma by expression of the mutant protein in COS or 3T3-L1 cells. The abilities of the P12A mutant of PPARgamma to mediate both transcriptional activation of a luciferase reporter gene construct containing the peroxisome proliferator response element and adipogenesis induced by a thiazolidinedione drug were reduced compared with those of the wild-type protein. These results suggest that the P12A substitution in PPARgamma gene may be associated with abnormalities of adipose tissue formation and insulin sensitivity.
Copyright 2000 Academic Press.
Similar articles
- Inhibition of adipogenesis by a COOH-terminally truncated mutant of PPARgamma2 in 3T3-L1 cells.
Masugi J, Tamori Y, Kasuga M. Masugi J, et al. Biochem Biophys Res Commun. 1999 Oct 14;264(1):93-9. doi: 10.1006/bbrc.1999.1488. Biochem Biophys Res Commun. 1999. PMID: 10527847 - A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.
Mukherjee R, Hoener PA, Jow L, Bilakovics J, Klausing K, Mais DE, Faulkner A, Croston GE, Paterniti JR Jr. Mukherjee R, et al. Mol Endocrinol. 2000 Sep;14(9):1425-33. doi: 10.1210/mend.14.9.0528. Mol Endocrinol. 2000. PMID: 10976920 - YM268 increases the glucose uptake, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes.
Shimaya A, Kurosaki E, Shioduka K, Nakano R, Shibasaki M, Shikama H. Shimaya A, et al. Horm Metab Res. 1998 Sep;30(9):543-8. doi: 10.1055/s-2007-978929. Horm Metab Res. 1998. PMID: 9808320 - Modulation of PPARgamma activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis.
Wang M, Tafuri S. Wang M, et al. J Cell Biochem. 2003 May 1;89(1):38-47. doi: 10.1002/jcb.10492. J Cell Biochem. 2003. PMID: 12682906 Review. - The metabolic syndrome: peroxisome proliferator-activated receptor gamma and its therapeutic modulation.
Gurnell M, Savage DB, Chatterjee VK, O'Rahilly S. Gurnell M, et al. J Clin Endocrinol Metab. 2003 Jun;88(6):2412-21. doi: 10.1210/jc.2003-030435. J Clin Endocrinol Metab. 2003. PMID: 12788836 Review.
Cited by
- PPARG-LYPLAL1 Multi-Allelic Combination Associated with Obesity and Overweight in Mexican Adolescent Females.
Hernández-Tobías EA, Torres-Sánchez L, Noris G, Santana C, Samano MR, Arellano-Galindo J, Arenas-Sordo ML, Brooks D, Rodríguez-Ventura AL, Meraz-Ríos MA, Gómez R. Hernández-Tobías EA, et al. Ethn Dis. 2016 Oct 20;26(4):477-484. doi: 10.18865/ed.26.4.477. Ethn Dis. 2016. PMID: 27773974 Free PMC article. - Genetics of insulin resistance.
Mercado MM, McLenithan JC, Silver KD, Shuldiner AR. Mercado MM, et al. Curr Diab Rep. 2002 Feb;2(1):83-95. doi: 10.1007/s11892-002-0063-9. Curr Diab Rep. 2002. PMID: 12643127 Review. - The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis.
Gouda HN, Sagoo GS, Harding AH, Yates J, Sandhu MS, Higgins JP. Gouda HN, et al. Am J Epidemiol. 2010 Mar 15;171(6):645-55. doi: 10.1093/aje/kwp450. Epub 2010 Feb 23. Am J Epidemiol. 2010. PMID: 20179158 Free PMC article. Review. - Peroxisome proliferator-activated receptor gamma rs1801282 C>G polymorphism is associated with polycystic ovary syndrome susceptibility: a meta-analysis involving 7,069 subjects.
Zhang S, Wang Y, Jiang H, Liu C, Sun B, Chen S, Kang M, Tang W. Zhang S, et al. Int J Clin Exp Med. 2015 Oct 15;8(10):17418-29. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26770332 Free PMC article. - PPARGC1A rs3736265 G>A polymorphism is associated with decreased risk of type 2 diabetes mellitus and fasting plasma glucose level.
Zhu L, Huang Q, Xie Z, Kang M, Ding H, Chen B, Chen Y, Liu C, Wang Y, Tang W. Zhu L, et al. Oncotarget. 2017 Jun 6;8(23):37308-37320. doi: 10.18632/oncotarget.16307. Oncotarget. 2017. PMID: 28418876 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources